PrecisionLife
@precisionlife.bsky.social
Precision medicine for complex diseases. Creating better, more personalized diagnostics & treatments for unmet medical needs.
Join us for world-leading AI-led science, healthcare, diagnostics, & drug development.
Join us for world-leading AI-led science, healthcare, diagnostics, & drug development.
Why is precision urgently needed for GLP-1 coverage?
Demand is surging, costs remain high, and patient responses vary.
Predictive biomarkers can help payors prioritize coverage where GLP-1s deliver the most value, while protecting affordability and access.
#GLP1 #PrecisionMedicine #ValueBasedCare
Demand is surging, costs remain high, and patient responses vary.
Predictive biomarkers can help payors prioritize coverage where GLP-1s deliver the most value, while protecting affordability and access.
#GLP1 #PrecisionMedicine #ValueBasedCare
December 16, 2025 at 3:05 PM
Why is precision urgently needed for GLP-1 coverage?
Demand is surging, costs remain high, and patient responses vary.
Predictive biomarkers can help payors prioritize coverage where GLP-1s deliver the most value, while protecting affordability and access.
#GLP1 #PrecisionMedicine #ValueBasedCare
Demand is surging, costs remain high, and patient responses vary.
Predictive biomarkers can help payors prioritize coverage where GLP-1s deliver the most value, while protecting affordability and access.
#GLP1 #PrecisionMedicine #ValueBasedCare
Reposted by PrecisionLife
Those lovely people @actionforme.bsky.social have shared the recording of the webinar covering presentation of @precisionlife.bsky.social LOCOME results.
#MECFS #longcovid
www.youtube.com/watch?v=ITZ3...
#MECFS #longcovid
www.youtube.com/watch?v=ITZ3...
December 12, 2025 at 1:28 PM
Those lovely people @actionforme.bsky.social have shared the recording of the webinar covering presentation of @precisionlife.bsky.social LOCOME results.
#MECFS #longcovid
www.youtube.com/watch?v=ITZ3...
#MECFS #longcovid
www.youtube.com/watch?v=ITZ3...
WEBINAR TODAY:
Our researchers are unpacking the new ME genetics study today - join the live webinar to hear the findings first-hand and get your questions answered.
📅 Today
🕑 2PM GMT
🔗 Register: us02web.zoom.us/webinar/regi...
#pwME #MECFS #longCOVID #MissingMillions
Our researchers are unpacking the new ME genetics study today - join the live webinar to hear the findings first-hand and get your questions answered.
📅 Today
🕑 2PM GMT
🔗 Register: us02web.zoom.us/webinar/regi...
#pwME #MECFS #longCOVID #MissingMillions
December 5, 2025 at 10:58 AM
WEBINAR TODAY:
Our researchers are unpacking the new ME genetics study today - join the live webinar to hear the findings first-hand and get your questions answered.
📅 Today
🕑 2PM GMT
🔗 Register: us02web.zoom.us/webinar/regi...
#pwME #MECFS #longCOVID #MissingMillions
Our researchers are unpacking the new ME genetics study today - join the live webinar to hear the findings first-hand and get your questions answered.
📅 Today
🕑 2PM GMT
🔗 Register: us02web.zoom.us/webinar/regi...
#pwME #MECFS #longCOVID #MissingMillions
Reposted by PrecisionLife
Helen Baxter, Patient Advocate and PPI Representative:
"These results greatly enhance our understanding of the biology of ME and present opportunities for drug repurposing which affords hope to the millions of people living with #ME and #longCOVID around the world." @precisionlife.bsky.social
"These results greatly enhance our understanding of the biology of ME and present opportunities for drug repurposing which affords hope to the millions of people living with #ME and #longCOVID around the world." @precisionlife.bsky.social
The most detailed genetic analysis of myalgic encephalomyelitis ever conducted
Groundbreaking ME study identifies 250+ genes, links with long COVID, and uncovers new drug repurposing opportunities to advance targeted treatments
precisionlife.com
December 4, 2025 at 9:41 AM
Helen Baxter, Patient Advocate and PPI Representative:
"These results greatly enhance our understanding of the biology of ME and present opportunities for drug repurposing which affords hope to the millions of people living with #ME and #longCOVID around the world." @precisionlife.bsky.social
"These results greatly enhance our understanding of the biology of ME and present opportunities for drug repurposing which affords hope to the millions of people living with #ME and #longCOVID around the world." @precisionlife.bsky.social
Reposted by PrecisionLife
LOCOME Project: Major #ME and #LongCOVID Genetics Findings Announced. Today we are excited to share landmark new findings from the LOCOME project.
www.medrxiv.org/content/10.6...
@precisionlife.bsky.social
www.medrxiv.org/content/10.6...
@precisionlife.bsky.social
Identification of Novel Reproducible Combinatorial Genetic Risk Factors for Myalgic Encephalomyelitis in the DecodeME Patient Cohort and Commonalities with Long COVID
Background: Myalgic encephalomyelitis (also known as ME/CFS or simply ME) has severely impacted the lives of tens of millions of people globally, but the disease currently has no accurate diagnostic t...
www.medrxiv.org
December 4, 2025 at 9:14 AM
LOCOME Project: Major #ME and #LongCOVID Genetics Findings Announced. Today we are excited to share landmark new findings from the LOCOME project.
www.medrxiv.org/content/10.6...
@precisionlife.bsky.social
www.medrxiv.org/content/10.6...
@precisionlife.bsky.social
Reposted by PrecisionLife
Delighted how @precisionlife.bsky.social and @actionforme.bsky.social et al used consented @decodemestudy.bsky.social data to
-replicate #MEcfs genetic signal &
-show its shared/distinct genetics with Long Covid.
Next: replicate ME/CFS subtypes w/ targeted therapies
www.medrxiv.org/content/10.6...
-replicate #MEcfs genetic signal &
-show its shared/distinct genetics with Long Covid.
Next: replicate ME/CFS subtypes w/ targeted therapies
www.medrxiv.org/content/10.6...
Identification of Novel Reproducible Combinatorial Genetic Risk Factors for Myalgic Encephalomyelitis in the DecodeME Patient Cohort and Commonalities with Long COVID
Background: Myalgic encephalomyelitis (also known as ME/CFS or simply ME) has severely impacted the lives of tens of millions of people globally, but the disease currently has no accurate diagnostic t...
www.medrxiv.org
December 4, 2025 at 8:13 AM
Delighted how @precisionlife.bsky.social and @actionforme.bsky.social et al used consented @decodemestudy.bsky.social data to
-replicate #MEcfs genetic signal &
-show its shared/distinct genetics with Long Covid.
Next: replicate ME/CFS subtypes w/ targeted therapies
www.medrxiv.org/content/10.6...
-replicate #MEcfs genetic signal &
-show its shared/distinct genetics with Long Covid.
Next: replicate ME/CFS subtypes w/ targeted therapies
www.medrxiv.org/content/10.6...
Reposted by PrecisionLife
(1/4) 🧬 @precisionlife.bsky.social has released exciting results from the LOCOME project
Using DecodeME and other datasets, LOCOME has identified a number of genetic signals and biological pathways that may be involved in ME.
Using DecodeME and other datasets, LOCOME has identified a number of genetic signals and biological pathways that may be involved in ME.
December 4, 2025 at 8:26 AM
(1/4) 🧬 @precisionlife.bsky.social has released exciting results from the LOCOME project
Using DecodeME and other datasets, LOCOME has identified a number of genetic signals and biological pathways that may be involved in ME.
Using DecodeME and other datasets, LOCOME has identified a number of genetic signals and biological pathways that may be involved in ME.
New myalgic encephalomyelitis (ME, also known as ME/CFS) genetics study reveals 250+ core genes, shared mechanisms with long COVID, and dozens of drug repurposing opportunities. This would not have been possible without the thousands of people with ME who contributed their data.
Thank you.
Thank you.
December 4, 2025 at 8:00 AM
New myalgic encephalomyelitis (ME, also known as ME/CFS) genetics study reveals 250+ core genes, shared mechanisms with long COVID, and dozens of drug repurposing opportunities. This would not have been possible without the thousands of people with ME who contributed their data.
Thank you.
Thank you.
We’ve partnered with Ovation.io to identify biomarkers that predict which patients will respond safely and effectively to GLP-1 therapies.
The goal: help payors and providers achieve the best, most cost-effective outcomes for patients using GLP-1.
➡️ www.precisionlife.com/glp1 for more.
The goal: help payors and providers achieve the best, most cost-effective outcomes for patients using GLP-1.
➡️ www.precisionlife.com/glp1 for more.
PrecisionLife & Ovation partner to develop first precision medicine test to inform reimbursement of GLP-1 anti-obesity drugs
PrecisionLife and Ovation partner to develop real-world GLP-1 drug-response biomarkers to support value-based reimbursement and improve patient outcomes.
www.precisionlife.com
November 25, 2025 at 1:32 PM
We’ve partnered with Ovation.io to identify biomarkers that predict which patients will respond safely and effectively to GLP-1 therapies.
The goal: help payors and providers achieve the best, most cost-effective outcomes for patients using GLP-1.
➡️ www.precisionlife.com/glp1 for more.
The goal: help payors and providers achieve the best, most cost-effective outcomes for patients using GLP-1.
➡️ www.precisionlife.com/glp1 for more.
In a new article in Healthcare Leader, our CEO Steve Gardner explains how by understanding the biological mechanisms behind chronic conditions we can now predict and prevent complex diseases, improve diagnosis, treatment and patient outcomes. Read it here: precisionlife.com/healthcarele...
November 20, 2025 at 10:56 AM
In a new article in Healthcare Leader, our CEO Steve Gardner explains how by understanding the biological mechanisms behind chronic conditions we can now predict and prevent complex diseases, improve diagnosis, treatment and patient outcomes. Read it here: precisionlife.com/healthcarele...
Why would anyone take on what is arguably the most complex of the complex, chronic diseases?
That’s the question Cort Johnson, founder of leading patient advocacy site Health Rising, asks in his latest feature about our work in ME/CFS and Long COVID.
➡️ www.healthrising.org/blog/2025/10...
That’s the question Cort Johnson, founder of leading patient advocacy site Health Rising, asks in his latest feature about our work in ME/CFS and Long COVID.
➡️ www.healthrising.org/blog/2025/10...
October 30, 2025 at 2:53 PM
Why would anyone take on what is arguably the most complex of the complex, chronic diseases?
That’s the question Cort Johnson, founder of leading patient advocacy site Health Rising, asks in his latest feature about our work in ME/CFS and Long COVID.
➡️ www.healthrising.org/blog/2025/10...
That’s the question Cort Johnson, founder of leading patient advocacy site Health Rising, asks in his latest feature about our work in ME/CFS and Long COVID.
➡️ www.healthrising.org/blog/2025/10...
Yesterday at #TechBioUK - hosted by @bia-uk.bsky.social - our CEO Steve Gardner joined leaders from AstraZeneca, Healx and Recursion to explore the real-world impact of AI in drug development and healthcare – and what’s needed for it to reach its full potential.
What do you think?
What do you think?
October 17, 2025 at 1:01 PM
Yesterday at #TechBioUK - hosted by @bia-uk.bsky.social - our CEO Steve Gardner joined leaders from AstraZeneca, Healx and Recursion to explore the real-world impact of AI in drug development and healthcare – and what’s needed for it to reach its full potential.
What do you think?
What do you think?
Reposted by PrecisionLife
Our 2025 Big Survey is now open! 🎉
For more information, our FAQs, and to take part, head to our web page: www.actionforme.org.uk/research-campaigns/our-research-work/big-survey/
Thank you for supporting our research💙
🤝in collaboration with
@durhamimh.bsky.social @kacheston.bsky.social
For more information, our FAQs, and to take part, head to our web page: www.actionforme.org.uk/research-campaigns/our-research-work/big-survey/
Thank you for supporting our research💙
🤝in collaboration with
@durhamimh.bsky.social @kacheston.bsky.social
October 13, 2025 at 10:19 AM
Our 2025 Big Survey is now open! 🎉
For more information, our FAQs, and to take part, head to our web page: www.actionforme.org.uk/research-campaigns/our-research-work/big-survey/
Thank you for supporting our research💙
🤝in collaboration with
@durhamimh.bsky.social @kacheston.bsky.social
For more information, our FAQs, and to take part, head to our web page: www.actionforme.org.uk/research-campaigns/our-research-work/big-survey/
Thank you for supporting our research💙
🤝in collaboration with
@durhamimh.bsky.social @kacheston.bsky.social
Reposted by PrecisionLife
Thank you to Golda Arthur for inviting me to be on the Overlooked Pod. A curation of conversations about women's health from patients, clinicians and scientists. Highlighting @precisionlife.bsky.social's work in #endometriosis and #womenshealth
check out the series
overlookedpod.com/episode/a-ne...
check out the series
overlookedpod.com/episode/a-ne...
A new way of looking at endometriosis, with Rowan Gardner | Overlooked: women's health can't wait
Even a basic definition of endometriosis tells us a lot about why we need to rethink how we’re dealing with this condition. Rowan Gardner is co-founder of...
overlookedpod.com
October 5, 2025 at 1:01 PM
Thank you to Golda Arthur for inviting me to be on the Overlooked Pod. A curation of conversations about women's health from patients, clinicians and scientists. Highlighting @precisionlife.bsky.social's work in #endometriosis and #womenshealth
check out the series
overlookedpod.com/episode/a-ne...
check out the series
overlookedpod.com/episode/a-ne...
Our SVP of Bioinformatics, Sayoni Das, shared new insights at #WomenInBiotech: 75 novel genes linked to #endometriosis, confirmed across diverse populations. A step toward faster diagnosis, better treatments, and real progress in #WomensHealth.
🔗 Study pre-print: www.medrxiv.org/content/10.1...
🔗 Study pre-print: www.medrxiv.org/content/10.1...
October 3, 2025 at 9:50 AM
Our SVP of Bioinformatics, Sayoni Das, shared new insights at #WomenInBiotech: 75 novel genes linked to #endometriosis, confirmed across diverse populations. A step toward faster diagnosis, better treatments, and real progress in #WomensHealth.
🔗 Study pre-print: www.medrxiv.org/content/10.1...
🔗 Study pre-print: www.medrxiv.org/content/10.1...
Our latest study, now in pre-print, has identified & validated 75 new genes linked to #endometriosis.
Actionable insights that will help shorten the 7–10 year diagnostic delay and lead to more effective, personalized treatments.
🔗 www.medrxiv.org/content/10.1...
#WomensHealth #PrecisionMedicine
Actionable insights that will help shorten the 7–10 year diagnostic delay and lead to more effective, personalized treatments.
🔗 www.medrxiv.org/content/10.1...
#WomensHealth #PrecisionMedicine
Identification and Validation of Novel Combinatorial Genetic Risk Factors for Endometriosis across Multiple UK and US Patient Cohorts
Background Endometriosis affects about 10% of women usually of reproductive age. It often has severe negative impacts on patients’ quality of life, but the average time to a definitive diagnosis remai...
doi.org
October 1, 2025 at 10:17 AM
Our latest study, now in pre-print, has identified & validated 75 new genes linked to #endometriosis.
Actionable insights that will help shorten the 7–10 year diagnostic delay and lead to more effective, personalized treatments.
🔗 www.medrxiv.org/content/10.1...
#WomensHealth #PrecisionMedicine
Actionable insights that will help shorten the 7–10 year diagnostic delay and lead to more effective, personalized treatments.
🔗 www.medrxiv.org/content/10.1...
#WomensHealth #PrecisionMedicine
This week we took part in the launch of Victoria House - London's new home for science and innovation.
Our team showcased Mechanostics® - accelerating diagnosis, improving outcomes, reducing costs, and moving chronic disease care from treatment to prevention.
#PrecisionMedicine #PrecisionLife
Our team showcased Mechanostics® - accelerating diagnosis, improving outcomes, reducing costs, and moving chronic disease care from treatment to prevention.
#PrecisionMedicine #PrecisionLife
September 18, 2025 at 4:25 PM
This week we took part in the launch of Victoria House - London's new home for science and innovation.
Our team showcased Mechanostics® - accelerating diagnosis, improving outcomes, reducing costs, and moving chronic disease care from treatment to prevention.
#PrecisionMedicine #PrecisionLife
Our team showcased Mechanostics® - accelerating diagnosis, improving outcomes, reducing costs, and moving chronic disease care from treatment to prevention.
#PrecisionMedicine #PrecisionLife
🎥 As part of today’s recognition of #SevereME, we’re sharing this recent presentation by our Co-founder, Rowan Gardner (@rowanbio.bsky.social), given at International ME Conference: 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗧𝗲𝘀𝘁𝘀 𝗮𝗻𝗱 𝗣𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗠𝗘.
August 8, 2025 at 2:48 PM
🎥 As part of today’s recognition of #SevereME, we’re sharing this recent presentation by our Co-founder, Rowan Gardner (@rowanbio.bsky.social), given at International ME Conference: 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗧𝗲𝘀𝘁𝘀 𝗮𝗻𝗱 𝗣𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗠𝗘.
𝗧𝗼𝗱𝗮𝘆 𝗶𝘀 𝗦𝗲𝘃𝗲𝗿𝗲 𝗠𝗘 𝗗𝗮𝘆 – a moment to acknowledge the strength, resilience, and determination of those living with the most debilitating forms of Myalgic Encephalomyelitis.
August 8, 2025 at 2:29 PM
𝗧𝗼𝗱𝗮𝘆 𝗶𝘀 𝗦𝗲𝘃𝗲𝗿𝗲 𝗠𝗘 𝗗𝗮𝘆 – a moment to acknowledge the strength, resilience, and determination of those living with the most debilitating forms of Myalgic Encephalomyelitis.
Millions are still waiting for answers. Ahead of #SevereMEAwarenessDay, we’re reaffirming our support and using genetic insights to develop the first non-invasive mechanostic tests to accelerate diagnosis and improve care.
🔗 precisionlife.com/blog-support...
#MECFS #LongCOVID
🔗 precisionlife.com/blog-support...
#MECFS #LongCOVID
August 6, 2025 at 11:00 AM
Millions are still waiting for answers. Ahead of #SevereMEAwarenessDay, we’re reaffirming our support and using genetic insights to develop the first non-invasive mechanostic tests to accelerate diagnosis and improve care.
🔗 precisionlife.com/blog-support...
#MECFS #LongCOVID
🔗 precisionlife.com/blog-support...
#MECFS #LongCOVID
We fully support our partners at @actionforme.bsky.social in their response to the UK government's ME/CFS Delivery Plan as a positive and necessary step forward – but that much more is needed to deliver real change, faster, for people with ME. #pwME #MECFS #MyalgicE #MyalgicEncephalomyelitis
1/4
❗️ DHSC publishes the Final Delivery Plan on ME/CFS
The Department of Health & Social Care has published the Final Delivery Plan on #MECFS
We have issued a detailed statement on our website 👇
www.actionforme.org.uk/dhsc-publish...
#pwME #MyalgicE #MyalgicEncephalomyelitis #FundThePlan
⬇️
❗️ DHSC publishes the Final Delivery Plan on ME/CFS
The Department of Health & Social Care has published the Final Delivery Plan on #MECFS
We have issued a detailed statement on our website 👇
www.actionforme.org.uk/dhsc-publish...
#pwME #MyalgicE #MyalgicEncephalomyelitis #FundThePlan
⬇️
July 24, 2025 at 3:04 PM
We fully support our partners at @actionforme.bsky.social in their response to the UK government's ME/CFS Delivery Plan as a positive and necessary step forward – but that much more is needed to deliver real change, faster, for people with ME. #pwME #MECFS #MyalgicE #MyalgicEncephalomyelitis
Reposted by PrecisionLife
1-hour recording from AfME’s Genetics Centre of Excellence webinar:
"Presentations from Audrey Ryback, Research Fellow at the University of Edinburgh (funded by Action for ME), and PrecisionLife, our Partners in the LOCOME research project."
www.youtube.com/watch?v=zhNt...
#MEcfs #CFS #PwME
"Presentations from Audrey Ryback, Research Fellow at the University of Edinburgh (funded by Action for ME), and PrecisionLife, our Partners in the LOCOME research project."
www.youtube.com/watch?v=zhNt...
#MEcfs #CFS #PwME
Genetics Centre of Excellence Webinar - 06 June 2025
YouTube video by Action For ME
www.youtube.com
June 29, 2025 at 11:10 AM
1-hour recording from AfME’s Genetics Centre of Excellence webinar:
"Presentations from Audrey Ryback, Research Fellow at the University of Edinburgh (funded by Action for ME), and PrecisionLife, our Partners in the LOCOME research project."
www.youtube.com/watch?v=zhNt...
#MEcfs #CFS #PwME
"Presentations from Audrey Ryback, Research Fellow at the University of Edinburgh (funded by Action for ME), and PrecisionLife, our Partners in the LOCOME research project."
www.youtube.com/watch?v=zhNt...
#MEcfs #CFS #PwME
Chronic diseases overwhelm health systems, yet most lack accurate risk prediction or effective treatment. In a new insight article, our CEO explores how mechanism-based precision medicine can change that.
🔗 precisionlife.com/future-now
#PrecisionMedicine
#PrecisionLife
🔗 precisionlife.com/future-now
#PrecisionMedicine
#PrecisionLife
July 9, 2025 at 10:13 AM
Chronic diseases overwhelm health systems, yet most lack accurate risk prediction or effective treatment. In a new insight article, our CEO explores how mechanism-based precision medicine can change that.
🔗 precisionlife.com/future-now
#PrecisionMedicine
#PrecisionLife
🔗 precisionlife.com/future-now
#PrecisionMedicine
#PrecisionLife
Delighted to feature in the @bia-uk.bsky.social report on functional genomics as an example of its transformative power in UK healthcare.
Proud to work at the intersection of AI and genomics - understanding complex biology to predict & prevent chronic diseases.
🔗 bioindustry.org/resource-rep...
Proud to work at the intersection of AI and genomics - understanding complex biology to predict & prevent chronic diseases.
🔗 bioindustry.org/resource-rep...
Functional genomics explainer: A strategic opportunity for the UK
bioindustry.org
July 3, 2025 at 10:05 AM
Delighted to feature in the @bia-uk.bsky.social report on functional genomics as an example of its transformative power in UK healthcare.
Proud to work at the intersection of AI and genomics - understanding complex biology to predict & prevent chronic diseases.
🔗 bioindustry.org/resource-rep...
Proud to work at the intersection of AI and genomics - understanding complex biology to predict & prevent chronic diseases.
🔗 bioindustry.org/resource-rep...
Watch our full presentation (clip below) in the recent @actionforme.bsky.social webinar on ME/CFS & long COVID.
We explore genetic risk factors, protective biology, and precision biomarkers that could transform diagnosis and treatment.
🎥 precisionlife.com/webinar-upda...
#MECFS #LongCOVID
We explore genetic risk factors, protective biology, and precision biomarkers that could transform diagnosis and treatment.
🎥 precisionlife.com/webinar-upda...
#MECFS #LongCOVID
July 1, 2025 at 11:25 AM
Watch our full presentation (clip below) in the recent @actionforme.bsky.social webinar on ME/CFS & long COVID.
We explore genetic risk factors, protective biology, and precision biomarkers that could transform diagnosis and treatment.
🎥 precisionlife.com/webinar-upda...
#MECFS #LongCOVID
We explore genetic risk factors, protective biology, and precision biomarkers that could transform diagnosis and treatment.
🎥 precisionlife.com/webinar-upda...
#MECFS #LongCOVID